Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa specificity trial of C-Tb skin test in BCG-vaccinated healthy adults
2009-017296-17Phase 2Completed
- Sponsor
- Statens Serum Institut
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of C-Tb in Tuberculosis (TB) (2 arms), sponsored by Statens Serum Institut. Primary endpoint: Diameter of induration for C-Tb and Tuberculin PPD RT23 SSI. Started Nov 2010; status: completed.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on 2009-017296-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017296-17.